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Abstract
Protein phosphatase 1 (PP1) is one of the major protein phosphatases in eukaryotic cells. It
plays a key role in regulating glycogen synthesis, by dephosphorylating crucial enzymes
involved in glycogen homeostasis such as glycogen synthase (GS) and glycogen phos-
phorylase (GP). To play this role, PP1 binds to specific glycogen targeting subunits that, on
one hand recognize the substrates to be dephosphorylated and on the other hand recruit
PP1 to glycogen particles. In this work we have analyzed the functionality of the different
protein binding domains of one of these glycogen targeting subunits, namely PPP1R3D
(R6) and studied how binding properties of different domains affect its glycogenic proper-
ties. We have found that the PP1 binding domain of R6 comprises a conserved RVXF motif
(R102VRF) located at the N-terminus of the protein. We have also identified a region located
at the C-terminus of R6 (W267DNND) that is involved in binding to the PP1 glycogenic sub-
strates. Our results indicate that although binding to PP1 and glycogenic substrates are
independent processes, impairment of any of them results in lack of glycogenic activity of
R6. In addition, we have characterized a novel site of regulation in R6 that is involved in
binding to 14-3-3 proteins (RARS74LP). We present evidence indicating that when binding
of R6 to 14-3-3 proteins is prevented, R6 displays hyper-glycogenic activity although is rap-
idly degraded by the lysosomal pathway. These results define binding to 14-3-3 proteins as
an additional pathway in the control of the glycogenic properties of R6.
Introduction
The control of glycogen homeostasis occurs via an exquisite coordination of events. These
events comprises from the regulation of glucose intake to the control of glycogen synthesis and
breakdown, amongst others. The key enzymes involved in glycogen metabolism are the glyco-
gen synthase (GS) and glycogen phosphorylase (GP). The dephosphorylation of these enzymes
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by the protein phosphatase 1 (PP1) results in the stimulation of glycogen synthesis by activat-
ing GS, and the prevention of glycogen breakdown by inactivating GP, which leads to the net
accumulation of the polysaccharide [1]. However, these PP1 glycogenic substrates establish
only weak interactions with the phosphatase catalytic subunit (PP1c), thus the process requires
the mediation of PP1 regulatory subunits to allow an efficient dephosphorylation ([2], [3]). In
this context, it has been described until now seven glycogen targeting subunits [PPP1R3A
(GM), PPP1R3B (GL), PPP1R3C (R5/PTG), PPP1R3D (R6), PPP1R3E (R3E), PPP1R3F (R3F)
and PPP1R3G (R3G); [1], [3]] that serve as scaffold proteins. These glycogen targeting subunits
not only provide additional docking sites for PP1 glycogenic substrates but also recruit the
phosphatase to the glycogen particle, where the concentration of the substrates is higher.
Therefore, to accomplish their function, the glycogen targeting subunits need to bind to the
PP1c catalytic subunit, to the PP1 glycogenic substrates and also to the glycogen particle ([1],
[2], [3]).
PP1c is one of the major protein phosphatase involved in many different processes in
eukaryotic cells. The specificity for the substrates that is able to dephosphorylate is given by its
binding to a particular regulatory subunit. At present, more than one hundred different PP1
regulatory subunits have been defined [4], and although they do not show any overall degree of
homology, most of them share a common docking motif for PP1 binding, named the RVXF
motif ([2], [3]). This motif is present in the glycogen targeting subunits described above [5],
although its functionality has only been proven in GM (R63VSF) ([6], [7]), GL (R62VSF) ([6],
[7]), R5/PTG (R84VVF) [8] and R3F (R36VLF) [9]. These glycogenic subunits also bind to the
PP1 substrates (i.e., GS and GP) to allow their efficient dephosphorylation by the PP1 phospha-
tase. It was postulated that binding of glycogen targeting subunits to these substrates was medi-
ated by a conserved sequence WXNXGNYX(L/I) [5]. However, at present, the functionality of
this domain has only been demonstrated in the case of GM (W219SNNN, [10]) and R5/PTG
(W222DSNR, [11]). Finally, these glycogenic subunits contain a carbohydrate binding module
of the CBM21 type ([12], [13]) that allows their binding to the glycogen particle [5]. This prop-
erty is crucial for the localization of the PP1 phosphatase to this specific subcellular compart-
ment where the glycogenic substrates are present.
In this work, we have characterized the different binding domains of the glycogen targeting
subunit PPP1R3D (R6) and have evaluated their functionality in regulating glycogen produc-
tion. R6 is a glycogenic subunit of 33 kDa widely distributed in a variety of tissues, including
liver, skeletal muscle, pancreas and brain ([14], [15]). In muscle cells R6 has a clear glycogenic
activity, which is higher than GM but lower that R5/PTG [16]. We have recently described that
the glycogenic activity of R6 is regulated by ubiquitination: R6 interacts with laforin, a dual
specificity phosphatase involved in Lafora disease (a type of progressive myoclonus epilepsy),
which targets R6 to malin, an E3-ubiquitin ligase also related to Lafora disease [17]. The action
of the laforin-malin complex results in the monoubiquitination and also in the polyubiquitina-
tion (through K63-linked chains) of R6, which results in an impairment of the glycogenic activ-
ity of this glycogen targeting subunit and the degradation of R6 through the lysosomal pathway
[17]. Recently, in a high-throughput screening, it was found that R6 potentially interacted with
14-3-3 proteins [18]. 14-3-3 family of proteins bind to Ser/Thr phosphorylated residues on tar-
get proteins producing a variety of different responses: for example, they can occlude a docking
region of the target protein, affect to the subcellular localization or provoke a conformational
change [19]. 14-3-3 proteins interact with their targets mainly via a consensus sequence
RSXpSXP [19], although it has been recently found that other residues outside the canonical
motif may be required to strength binding [20]. Here we show that R6 possesses a consensus
motif for 14-3-3 protein binding, RARS74LP, not present in other glycogenic subunits such as
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R5/PTG or GL, and demonstrate that binding to 14-3-3 proteins affects the glycogenic proper-
ties of R6 and its rate of lysosomal degradation.
Materials and Methods
Plasmids
pFLAG-R6, pBTM-R6, pGADT7-R6, pACT2-laforin, pACT2-PP1α and pEYFP-R6 constructs
were described previously ([17], [21], [22], [23]). pACT2-14-3-3ε plasmid was a generous gift
from Dra. Lynne Yenush (IBMCP, UPV-CSIC, Valencia, Spain). Mutant constructs pEYFP-R6
S25A, S74A, RARA, RAHA, WDNAD andWANNA were obtained by site directed mutagene-
sis using Quick-Change Mutagenesis kit and the corresponding mutagenic oligonucleotides
(see Table 1), according to the manufacturer’s protocol. Mutations were all confirmed by DNA
sequencing. The corresponding ORFs were subcloned into yeast pBTM116 and mammalian
pFLAG-6c vectors to allow their expression either in yeast or in mammalian cells.
Cell culture, transfection and treatments
Murine neuroblastoma Neuro-2a (N2a) and human embryonic kidney (Hek293) cells (from the
Health Protection Agency Culture Collection, Salisbury, UK) were grown in Dulbecco’s modi-
fied Eagle’s medium (Lonza, Barcelona, Spain), supplemented with 100 units/ml penicillin,
100 μg/ml streptomycin, 2 mM glutamine and 10% of inactivated fetal bovine serum (Invitro-
gen, Madrid, Spain) in a humidified atmosphere at 37°C with 5% CO2. Cells were transfected
with 1 μg of each plasmid using either X-treme GENE HP transfection reagent (Roche Diagnos-
tics, Barcelona, Spain) or Lipofectamine 2000 (Invitrogen, Madrid, Spain), according to the
manufacturer’s instructions. When indicated, 18 hours after transfection, cells were treated with
MG132 (5 μM) or ammonium chloride (20 mM)/ leupeptin (100 μM) for 6 hours. Alternatively,
cells were also treated with cycloheximide (300 μM) for the indicated times.
Preparation of crude extracts and immunoblotting
Cell extracts were prepared using lysis buffer [25 mM Tris-HCl at pH 7.5, 15 mM EDTA at pH
8, 50 mMNaF, 0.6 M sucrose, 15 mM 2-mercaptoethanol, 15 mM Na4P2O7, 1 mM PMSF, and
a complete Mini-EDTA free protease inhibitor mixture (Roche Diagnostics, Barcelona,
Table 1. Primers used for site directedmutagenesis.
MUTATION FORWARD PRIMER REVERSE PRIMER
S25A AAG CTC GGC CCC CGG AGC CTC
GCA TGC CTG TCG GAC CTG GAC
GGC
GCC GTC CAG GTC CGA CAG GCA
TGC GAG GCT CCG GGG GCC GAG
CTT
S74A ATC ATC CTG CGG CGG GCC CGG
GCA CTG CCC AGC TCC CCC GAG
CGC
GCG CTC GGG GGA GCT GGG CAG
TGC CCG GGC CCG CCG CAG GAT
GAT
V103A-F105A
(RARA)
TGC AGC CAG AAG CTC CGC GCC
CGG GCC GCC GAC GCC CTG GGC
TTG
CAA GCC CAG GGC GTC GGC GGC
CCG GGC GCG GAG CTT CTG GCT
GCA
V253A-F255A
(RAHA)
GAG CTC GGC TCC CGC GCG CAC
GCC GCG GTG CGC TAC CAA
TTG GTA GCG CAC CGC GGC GTG
CGC GCG GGA GCC GAG CTC
N270A (WDNAD) GCC GAG TAC TGG GAC AAC GCC
GAC CAC AGA GAC TAC AGC
GCT GTA GTC TCT GTG GTC GGC
GTT GTC CCA GTA CTC GGC
D268A-D271A
(WANNA)
GCG GGT GCC GAG TAC TGG GCC
AAC AAC GCC CAC AGA GAC TAC
AGC
GCT GTA GTC TCT GTG GGC GTT
GTT GGC CCA GTA CTC GGC ACC
CGC
doi:10.1371/journal.pone.0131476.t001
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Spain)]. Cells were lysed by repeated passage through 24Gx5/8” needle and centrifuged at
13,000xg 10 min. Thirty micrograms of total protein from the soluble fraction of cell lysates
were analyzed by SDS-PAGE and Western blotting using appropriated antibodies: anti-FLAG,
anti-HA and anti-actin (Sigma-Aldrich, Madrid, Spain); anti-tubulin, anti-LexA and anti-
PP1α (Santa Cruz Biotechnology, Barcelona, Spain); anti-GS (rabbit monoclonal antibody
against the C-term of muscular glycogen synthase) and anti-GP (mouse monoclonal against
the muscular isoform of the glycogen phosphorylase) (Abcam, Cambridge Science Park, UK);
anti-14-3-3ε (Abgent, San Diego, USA) and anti-GFP (ImmunoK, AMS Biotechnology LTD.).
Secondary antibodies were from Santa Cruz Biotechnology (Barcelona, Spain). Immunoblots
were analyzed by using ECLprime reagent (GE Healthcare, Barcelona, Spain) and chemilumi-
nescence was detected using a Fujifilm LAS- 4000 Lite imager.
Yeast two-hybrid analysis
Yeast THY-AP4 strain [MATα ura3 leu2 trp1 lexA::lacZ lexA::HIS3 lexA::ADE2] [24] was co-
transformed with plasmids pBTM-R6 (encoding LexA-R6 wild type and the corresponding
mutants) and pACT2 (GAD, empty plasmid), pACT2-PP1α (GAD-PP1), pACT2-laforin
(GAD-laforin) or pACT2-14-3-3ε (GAD-14-3-3). Yeast transformants were grown in selec-
tive SC medium and β-galactosidase activity was assayed in permeabilized cells and expressed
in Miller units as in [25]. Protein levels in crude extracts were analyzed by western blotting as
in [17].
Immunoprecipitation (GFP-Trap analysis)
Hek293 cells were transiently transfected with expression vectors coding for YFP, YFP-R6 wild
type, YFP-R6 S25A, YFP-R6 S74A, YFP-R6 RARA, YFP-R6 RAHA, YFP-R6 WDNAD or
YFP-R6 WANNA plasmids. After twenty-four hours of transfection, cells were scraped on ice
with 1 mL ice cold PBS and transferred to a pre-cooled tube to spin the cells at 500xg for 3 min.
After two PBS washes, pelleted cells were resuspended in 200 μL lysis buffer [25 mM Tris-HCl
pH 7,5; 150 mMNaCl, 0,5 mM EDTA, 5% glycerol, 0,5% nonidet P-40 (NP-40), complete pro-
tease inhibitor cocktail (Roche Diagnostics, Barcelona, Spain), 1 mM PMSF, 5 mMNaF and 5
mMNa4P2O7]. Cell lysates were placed on ice for 30 min and centrifuged at 13,000×g for 15
min at 4°C. An aliquot of the supernatant was used to determine protein concentration (Brad-
ford method). Two mg of the supernatant was incubated under rotation with 20 μL of pre-
equilibrated GFP-Trap_A bead slurry (Chromotek, Germany) for 10 min at 4°C. After exten-
sive washing, beads were resuspended with 100 μL of 2xSDS-sample buffer, eluted by heating
10 min at 95°C and centrifuged. 40 μL of eluted beads and thirty micrograms of total protein
from the soluble fraction of cell lysates were analyzed by SDS-PAGE and Western blotting
using appropriated antibodies.
Multiple sequence alignment and homology model
Amino acid sequences of PPP1R3B (GL), PPP1R3C (R5) and PPP1R3D (R6) from H. sapiens
were obtained from Uniprot database (accession numbers Q86XI6, Q9UQK1 and O95685,
respectively) and aligned using the Clustal Omega program (http://www.ebi.ac.uk/Tools/
msa/clustalo/). To adjust the alignment we used secondary structure prediction (GOR4 pro-
gram, [26]). Homology model was generated by SWISS-MODELWorkspace ([27], [28])
based on template of PPP1R3B (GL) (pdb accession code: 2EEF; Tomizawa et al., unpub-
lished data). Quality of protein model was estimated by QMEAN4 [29] and Ramachandran
plot evaluation by RAMPAGE program [30]. Images were generated using PyMol (DeLano
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Scientific LLC, USA). PhosphoSite was used for consensus phosphorylation site detection
(www.phosphosite.org).
Glycogen determination
Neuro-2a cells were transfected with the indicated plasmids. Forty-eight hours after transfec-
tion, cells were scraped on ice into 30% KOH and then heated at 100°C for 15 min. Glycogen
was measured as described previously [31] and expressed as μg of glucose per mg of protein.
Immunofluorescence and confocal microscopy
Neuro-2a cells transfected with the indicated plasmids were grown on 12-well plates containing
coverslips. Cells were fixed with 4% paraformaldehyde in phosphate-buffered saline (PBS) for
10 min. Then, they were permeabilized with 0.2% Triton X-100 in PBS for 15 min, washed
three times with PBS and blocked one hour with 10% fetal bovine serum, 5% nonfat dried
milk, 0,5% bovine serum albumin, and 0.1% Triton X-100 in PBS. Cells were then incubated
overnight at 4°C with 1/200 dilution of anti-glycogen antibody (a generous gift from Dr. Otto
Baba; Tokyo Medical and Dental University, Japan). Samples were washed three times with
PBS and incubated with a 1/500 dilution of anti-mouse IgM antibodies coupled to Alexa-Fluor
633. Then, cells were washed three times with PBS and mounted on slices using Aqua-Poly/
Mount coverslipping medium (Polysciences, Inc. Eppelheim, Germany). For R6 and glycogen
subcellular localization, images were acquired with a Leica TCS SL confocal microscope (Leica,
Wetzlar, Germany) using a PL APO 63× oil 1.4 N.A. immersion objective. Images were treated
with the ImageJ 1.43c software (Wayne Rasband, National Institutes of Health, Bethesda, MD).
Statistical data analysis
Data are expressed as means with standard deviation. Statistical significance of differences
between the groups was evaluated by a paired Student’s t-test with two-tailed distribution. The
significance has been considered at p<0.05, p<0.01, p<0.001, as indicated in each case.
Results
Characterization and structural modelling of R6 protein domains
Amultiple sequence protein alignment between PPP1R3B (GL), PPP1R3C (R5/PTG) and
PPP1R3D (R6) of H. sapiens (Fig 1A) allowed the definition of different characteristic protein
domains in R6. As PP1 glycogen-targeting subunits, all these proteins possess protein motifs
for binding to both the PP1 catalytic subunit (PP1c) and the glycogenic PP1 substrates [i.e. gly-
cogen synthase (GS), glycogen phosphorylase (GP)]. The named-RVXF- motif is the primary
PP1-docking motif present in about 70% of all PP1 interacting proteins ([2], [3]). Two putative
RVXF sequences can be found in R6, R102VRF and R252VHF. However, only the R102VRF
sequence was conserved in the three mammalian subunits tested (Fig 1A, first orange box),
being the second putative R252VHF motif only present in R6 (Fig 1A, second orange box at the
C-terminus). It has been described that the binding of glycogenic targeting subunits to glyco-
gen-related protein substrates occurs via a single highly conserved WDNNE/D motif ([10],
[11]). This motif was located at the C-terminus of R6 (W267DNND) (Fig 1A, cyan box). In
addition, glycogenic targeting subunits contain a carbohydrate binding module of the CBM21
type ([12], [13]) that allows binding of these subunits to glycogen. In the case of R6 this domain
spans from residue 169 to 278 (underlined region in Fig 1A).
To estimate the relative position of these motifs in the overall structure of the protein we
generated an homology model using as a template the NMR structure of the GL protein (pdb
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Fig 1. Characterization and structural modelling of R6 domains. (A) Multiple sequence alignment of PPP1R3D (R6), PPP1R3C (R5) and PPP1R3B (GL)
proteins sequences from H. sapiens (Uniprot entries: O95685, Q9UQK1 and Q86XI6, respectively) was performed using the Clustal Omega program (see
Materials and Methods). Invariance and conservation are highlighted by black and gray shadowing respectively. Amino acid sequences for the binding to 14-
3-3 proteins, PP1 catalytic subunit and PP1 glycogenic substrates are enclosed in yellow, orange and cyan boxes respectively. Brackets indicate the
modeled sequence of R6 shown in panel B. The CBM21 domain of R6 (according to Uniprot) is underlined in orange. Red triangles point at the mutated
residues obtained in this study. (B) Homology model of the CBM21 domain of R6 was based on the template of GL (pdb entry: 2EEF). The amino acids
corresponding to the PP1 glycogenic substrate binding domain (W267DNND) and to the putative RVXF (R252VHF) are shown in sticks and colored in cyan or
orange, respectively (left panel). The N- and C-terminus of the model is also indicated. A representation of the surface of the R6 homology model to show the
exposed amino acids to the solvent is presented in the right panel. Images were generated using PyMol (DeLano Scientific LLC, USA).
doi:10.1371/journal.pone.0131476.g001
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accession code: 2EEF). To validate the model we used secondary structure prediction from the
protein sequence and analyzed the Ramachandran plot, which had good statistics (88.4% in the
favored region). The model spans from residue 153 to 286 in R6 (Fig 1A, region within brack-
ets), covering the entire CBM21 domain and containing the second putative R252VHF motif
and the W267DNNDmotif involved in binding to PP1 substrates (Fig 1B). The modelled region
shows a typical β-barrel structure, with seven β-strands arranged into two major β-sheets. One
of these β-sheets consists of one parallel and one antiparallel β-strand pair, whereas the second
sheet is a four-stranded antiparallel β-sheet. The model also shows the presence of an α-helix
that is located on one side of the β-barrel structure (Fig 1B). It is interesting to note that in this
model the W267DNNDmotif is clearly exposed to the solvent, what would allow the interaction
of R6 with PP1 substrates. On the contrary, the putative R252VHF motif seems to be partially
buried in the model, what suggests poor PP1 binding properties for this motif (Fig 1B).
Assessing the functionality of the putative RVXF motifs of R6 in PP1c
binding
To assess the functionality of the different domains of R6 that we have described above, we
generated different mutants in the corresponding protein motifs and checked whether the
interaction with different partners was affected. We analyzed first the putative RVXF motifs
involved in the interaction with PP1c. The hydrophobic residues valine and phenylalanine
within the RVXF motifs were substituted for alanine, resulting in R102ARA and R252AHA
mutants. By yeast two-hybrid analyses we checked the interaction of these mutated forms with
the PP1 catalytic subunit (PP1c). In addition, we checked their interaction with laforin, a glu-
can phosphatase involved in Lafora disease, and with 14-3-3ε proteins, as they are potential
interaction partners of R6 [18]. Unfortunately the interaction of R6 with glycogenic substrates,
such as glycogen synthase (GS), was undetectable by yeast two-hybrid, what precluded the
analysis of the effect of the generated mutations on the interaction with this substrate using
this technique. As shown in Fig 2A, mutations in the R102VRF motif (R6-RARAmutant) dis-
rupted the binding to PP1c, although the binding to other interacting partners (laforin and 14-
3-3ε) remained as wild type. However, mutations in the R252VHF motif (R6-RAHAmutant)
impaired the binding to PP1c and also to the other interaction partners, despite the construct
was successfully produced, suggesting that the mutations had affected the overall structure of
the protein when expressed in yeast (Fig 2A). In order to confirm these results, we performed
an immunoprecipitation analysis in mammalian Hek293 cells expressing YFP-tagged versions
of either R6-RARA or R6-RAHAmutants and compared the results with the wild type form of
R6. As shown in Fig 3A, using the GFP-Trap technique, we confirmed that YFP-R6-RARA had
completely lost the interaction to endogenous PP1c. This mammalian system allowed us to
study the interaction of the different mutants with endogenous glycogenic substrates. In this
sense, we observed that the YFP-R6-RARA mutant was still able to interact with endogenous
GS and GP (although to at a lesser extend in the latter case), thus indicating that binding to
these PP1 substrates was independent to the binding to PP1c. Binding of YFP-R6-RARA to
endogenous 14-3-3ε protein was also not affected (Fig 3A). We were not able to check the
binding to endogenous laforin as the levels of this protein were very low in these cells (not
shown). On the contrary, we found that the YFP-R6-RAHAmutant was able to interact with
the endogenous PP1c catalytic subunit (Fig 3A), therefore discarding the R252VHF motif as an
area of contact to PP1c. The discrepancy between these results and the data obtained by yeast
two-hybrid could be due to the different expression systems, yeast vsmammalian cells, being
the latter more complete as it has endogenous levels of all glycogenic enzymes. Although the
R6-RAHAmutant interacted with endogenous 14-3-3ε proteins, it had an impaired interaction
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with the endogenous PP1 substrates GS and GP (Fig 3A). Probably, the introduced mutations
could have altered the conformation of the protein and affected the functionality of the
W267DNND substrate binding motif present in the near vicinity (Fig 1B) (see below).
Assessing the functionality of the WDNND substrate binding motif in R6
As indicated above, R6 contains a W267DNNDmotif possibly involved in binding to PP1 sub-
strates (Fig 1A, cyan box). To check the functionality of this region, and since it has been
described that in the case of the motif present in R5/PTG the acidic residues (Asp and Glu in
the murine form of R5/PTG) were key for substrate binding [11], we decided to substitute the
two Asp residues present in the R6 motif (Asp268 and Asp271) to alanine, resulting in the
R6-WANNAmutant. Alternatively, we decided to replace the second asparagine residue
(Asn270) to alanine, resulting in R6-WDNADmutant. We expressed these mutated forms in
yeast and analyzed their interaction with PP1c, laforin and 14-3-3ε proteins by yeast two-
hybrid. We observed that the R6-WDNADmutant presented a similar interaction pattern as
wild type with all the studied proteins: PP1c, laforin and 14-3-3ε proteins (Fig 2B). However,
the R6-WANNAmutant did not interact with any of the studied proteins, despite being
expressed in yeast (Fig 2B). In order to study the interaction profile of these mutants in a mam-
malian system, we constructed the corresponding YFP-fusion proteins (YFP-R6-WDNAD and
YFP-R6-WANNA) and expressed them in Hek293 cells. As shown in Fig 3B, the R6-WDNAD
mutant was able to interact with endogenous PP1c, GS, GP and 14-3-3ε proteins, suggesting
that the mutation had not affected the binding properties of R6. On the contrary, the
R6-WANNAmutant, although conserved the ability to interact with endogenous PP1c and 14-
Fig 2. Analysis of the interacting properties of different domains of R6 by yeast two-hybrid analyses.Upper panels: yeast THY-AP4 strain was
transformed with plasmids pBTM-R6 wt (LexA-R6), pBTM-R6 RARA and pBTM-R6 RAHA (A), pBTM-R6WDNAD, and pBTM-WANNA (B) or pBTM-R6
S25A and pBTM-R6 S74A (C) and with pACT2 (GAD), pACT2-PP1α (GAD-PP1α), pACT2-laforin (GAD-laforin) or pACT2-14-3-3ε (GAD-14-3-3ε). Protein
interaction was estimated by measuring the β-galactosidase activity. Values correspond to means from at least 6 different transformants (bars indicate
standard deviation). Lower panels: protein expression in yeast transformants was analyzed byWestern blotting using anti-HA antibodies (for the GAD-
fusions) and anti-LexA (for the LexA-fusions) in several transformants from each condition. A representative western blot of some of these transformants is
shown.
doi:10.1371/journal.pone.0131476.g002
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Fig 3. Analysis of the interacting properties of different domains of R6 by immunoprecipitation
(GFP-Trap) in mammalian cells.Hek293 cells were transiently transfected with expression vectors coding
for YFP, YFP-R6 wild type, and the corresponding mutants YFP-R6 RARA and YFP-R6 RAHA (A), YFP-R6
WDNAD and YFP-R6WANNA (B), or YFP-R6 S25A and YFP-R6 S74A plasmids (C). Immunoprecipitation
analyses were performed using GFP-Trap system (see Materials and Methods section). 40 μL of eluted
beads and thirty micrograms of total protein from the soluble fraction of cell lysates (input) were analyzed by
SDS-PAGE andWestern blotting using appropriated antibodies.
doi:10.1371/journal.pone.0131476.g003
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3-3ε proteins, the binding to the glycogenic substrates GP and GS was severely impaired (Fig
3B). These results confirmed the functionality of the W267DNNDmotif of R6 in substrate
binding.
Taking all these results together, we suggest that binding of R6 to PP1c occurs through the
R102VRF motif and binding of R6 to PP1 substrates occurs in a region comprising the
R252VHF and the W267DNNDmotifs, being the binding to PP1c and PP1 substrates indepen-
dent from each other. On the other hand, binding of R6 to 14-3-3ε proteins is independent
from these defined regions of R6.
Defining the 14-3-3 protein binding motif in R6
It is known that 14-3-3 proteins bind to Ser/Thr phosphorylated residues [19]. So, in order to
find the putative 14-3-3 binding domain in R6, we searched in the databases for reports on the
phosphorylation of R6 and found that it could be potentially phosphorylated in different resi-
dues: Ser23, Ser25, Ser28, Ser46, Ser74, Ser77, Ser78 and Ser133 ([32], [33], [34], [35]). How-
ever, only two of these sites, Ser25 and Ser74, could form part of the main putative 14-3-3
protein binding consensus motif-RSXpSXP- [19] (Fig 1A, yellow boxes). In order to study the
functionality of these sites on 14-3-3 protein binding, we produced non-phosphorylatable
mutants in which Ser25 or Ser74 were changed to alanine (S25A, S74A). Then, we assessed the
binding properties of the mutated forms by yeast two-hybrid analysis. As shown in Fig 2C,
binding of both R6-S25A and R6-S74A to the PP1c catalytic subunit and to laforin was similar
to wild type. However, although mutation at Ser25 did not affect the interaction with 14-3-3ε
proteins, mutation at Ser74 completely eliminated this interaction (Fig 2C). To confirm these
results in a mammalian system, we constructed the corresponding YFP-fusion proteins
(YFP-R6-S25A and YFP-R6-S74A), expressed them in Hek293 cells and carried out a GFP-
trap analysis. As shown in Fig 3C, R6-S25A mutant interacted with endogenous PP1c, GS, GP
and 14-3-3ε as wild type. In the case of the R6-S74A mutant it maintained the interaction with
endogenous PP1c, GS and GP (although in this latter case at lower levels), however the interac-
tion with endogenous 14-3-3ε was abolished (Fig 3C). All these results indicated that Ser74,
included in the RARS74LP motif, plays a crucial role in binding to 14-3-3 proteins, being this
interaction independent of the binding of R6 to PP1c and to PP1 glycogenic substrates.
Role of the different protein binding motifs on the glycogenic activity of R6
We have previously described that the expression of R6 in a neuroblastoma cell line (N2a) trig-
gers de novo glycogen synthesis. In these cells glycogen production is fully dependent on the
expression of functional PP1 glycogen targeting subunits since in its absence, glycogen produc-
tion is very low. The expression of PP1 glycogen targeting subunits, as R6, induces the dephos-
phorylation of endogenous GS leading to its activation, resulting in glycogen production [17].
To assess the glycogenic activity (capacity to induce glycogen synthesis) of the different R6
mutants we have described above, we expressed FLAG-tagged versions of them in N2a cells
and measured the glycogen levels after 48 h of transfection. Consistent with previous results,
expression of wild type R6 promoted the accumulation of glycogen (expressed as μg glucose/
mg protein/relative amount of FLAG-R6) (Fig 4A). Expression of the R6-RARA mutant, which
cannot bind to PP1c but binds to PP1 glycogenic substrates (GS, GP; see above), did not sup-
port the promotion of glycogen production (similar levels of glycogen were measured as in
cells transfected with an empty plasmid). Next, we analyzed the mutants that affected substrate
binding. When R6-RAHA and R6-WANNAmutants were expressed in N2a cells (they do not
bind to endogenous GS and GP enzymes; see above), the capacity to support glycogen produc-
tion was impaired as well, resulting in undetectable levels of glycogen. The expression of the
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R6-WDNADmutant, which interacts with PP1c and PP1 glycogenic substrates as wild type
(see above), produced amounts of glycogen comparable to the wild type protein. In summary,
mutations in R6 affecting the interaction with either PP1c or PP1 glycogenic substrates resulted
in an impairment of the glycogenic activity of the mutated forms.
We further investigated whether the binding of R6 to 14-3-3 proteins could affect the glyco-
genic properties of R6. We found that R6-S25A mutant was as glycogenic as wild type (Fig 4A).
Surprisingly, the expression of R6-S74A mutant, which is not able to bind to 14-3-3ε proteins
(see above), produced around 9 fold increase on glycogen accumulation (Fig 4A). In order to
explain the hyper-glycogenic properties of the R6-S74A mutant and since it has been reported
that binding to 14-3-3 proteins can affect the subcellular localization of a particular protein
[19], we investigated whether the lack of 14-3-3 protein binding present in R6-S74A could
have modified the subcellular localization of this protein. So, we expressed in N2a cells the
YFP-R6-S25A and YFP-R6-S74A mutants and assessed the subcellular distribution of these
Fig 4. Glycogenic activity of different mutated forms of R6. (A) Measurement of glycogenic activity of
different R6 mutated forms. N2a cells were transfected using 1 μg of pFLAG plasmid (negative control),
pFLAG-R6 plasmid or its corresponding mutants. Forty-eight hours after transfection, the amount of glycogen
was determined as described in Materials and Methods and represented as μg of glucose/mg of protein/
relative amount of R6 respect to actin (wild type value considered as 1). Bars indicate standard deviation of
three independent experiments (**p<0.01 or ***p<0.001, compared with control cells transfected with an
empty plasmid; ##p<0.01, compared with cells expressing R6-WT). An inset with the mean values +/-
standard deviation is included. (B) Protein levels of FLAG-R6 forms. A representative western blot analysis is
shown. Cell extracts (30 μg) were analyzed using the corresponding anti-FLAG and anti-actin antibodies.
doi:10.1371/journal.pone.0131476.g004
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proteins. As shown in Fig 5, R6-WT, R6-S25A and R6-S74A located in similar granular struc-
tures in the cytoplasm of N2a which contained glycogen, confirming previous results [17]. So,
we did not observe any change in the localization of the different mutants in comparison to the
wild type protein (Fig 5).
Binding of 14-3-3 to R6 prevents its lysosomal degradation
In the course of the subcellular localization experiments described above, we noticed that the
YFP-R6-S74A protein was expressed at much lower levels than the wild type or the R6-S25A
mutant (Fig 5). Similarly, lower levels of FLAG-R6-S74A were observed in Fig 4B (lane 5). In
order to analyze if mutation at Ser74 was affecting R6 stability, we performed an assay to com-
pare the half-life of this mutated form to the wild type protein. We expressed in Hek293 cells
either the FLAG-R6 wild type or the FLAG-R6-S74A mutant and treated the cells with cyclo-
heximide to block de novo protein synthesis. Then, protein levels were measured by western
blotting at different times after the treatment. As observed in Fig 6A, the R6-S74A protein had
a shorter half-life than the wild type protein. After 24h of treatment, the R6-S74A mutant was
degraded almost completely in comparison to the wild type form, which was rather stable (Fig
6A). To elucidate which mechanism of degradation was taking place, we treated the cells with
either MG132, to inhibit proteasome function, or with leupeptin and NH4Cl to inhibit lyso-
somal degradation [36]. We observed that treatment with MG132 did not affect the degrada-
tion of R6-S74A protein (Fig 6B). On the contrary, treatment with leupeptin and NH4Cl (to
block the lysosome) prevented the degradation of the R6-S74A mutated form (Fig 6B). There-
fore, disrupting the binding of 14-3-3 proteins to R6 accelerated its degradation by the lyso-
somal pathway.
Discussion
Protein phosphatase 1 (PP1) plays a crucial role in regulating glycogen synthesis. It dephos-
phorylates key enzymes involved in glycogen homeostasis, such as glycogen synthase (GS) and
glycogen phosphorylase (GP), leading to the activation of the former and the inactivation of
the latter, resulting in glycogen accumulation. However, PP1 does not interact directly with GS
or GP but binds to specific regulatory subunits that target PP1 to the glycogenic substrates. To
perform their function these PP1 glycogen targeting subunits must bind, on one hand to PP1
catalytic subunit (PP1c) and on the other hand to PP1 glycogenic substrates ([1], [3]). In this
work we have carried out a structure-function analysis of the different protein binding domains
we have identified in one of these glycogen targeting subunits, namely R6 (PPP1R3D) (Fig 7).
Our data indicates that R6 contains a typical RVXF motif (R102VRF) involved in PP1c binding
(Fig 7). This motif is also present in the other major glycogen targeting subunits studied so far
[PPP1R3A (GM): residues R63VSF; PPP1R3B (GL): residues R62VSF; PPP1R3C (R5/PTG):
R84VVF; numbering refers to the human counterpart of each protein, according to Uniprot].
We demonstrate that in R6 this motif is essential to maintain the ability of the protein to induce
glycogen synthesis. We also present data indicating that R6 contains a region (W267DNND)
involved in binding to glycogenic substrates (GS and GP) (Fig 7). This motif is well conserved
in other glycogen targeting subunits [PPP1R3A (GM): residues W219SNNN; PPP1R3B (GL):
residues W222DSNR; PPP1R3C (R5/PTG): residues W246DNND] but, to our knowledge, only
in the case of R6 (this work) and in the case of murine R5/PTG [11] and rabbit GM [10], the
functionality of this motif in glycogen synthesis has been evaluated. Consistent with its binding
properties, this domain is well exposed to the solvent in both the model we present for R6 (Fig
1B) and in the case of GL (pdb accession code: 2EEF). Our work indicates that R6 contains an
additional region regulating binding to PP1 glycogenic substrates, which is essential for the
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glycogenic activity of the targeting subunit: R256VHF (Fig 7). Although not conserved, a similar
region is present in R5/PTG (K231IEF) and GL (R207MEF) (Fig 1A), raising the possibility that
it could form part of an extended area of contact with PP1 glycogenic substrates that would
comprise in R6 from R256VHF to the W267DNND region (Fig 1B). Alternatively, and since the
hydrophobic residues (Val and Phe) in the R256VHF domain (mutated in the R6-RAHA form
which has impaired interaction with glycogenic substrates) are buried and not exposed to the
solvent in the structural model we present (Fig 1B) and also in the case of GL (pdb accession
code: 2EEF), they could participate in intramolecular contacts, so when they are changed to
Ala residues a conformational modification in this area could happen, affecting the binding
Fig 5. Subcellular localization of R6 S25A and R6 S74Amutated forms.N2a cells were transfected with
pYFP empty plasmid, pYFP-R6 wild type, pYFP-R6 S25A or pYFP-R6 S74A plasmids. The subcellular
localization of R6 forms and glycogen granules was carried out as described in Materials and Methods.
Images were obtained by using confocal microscopy (bars indicate 10 μm). Images corresponding to visible,
YFP (in yellow) and glycogen (in red) fluorescences are shown.
doi:10.1371/journal.pone.0131476.g005
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properties of the W267DNNDmotif that is nearby (Fig 1B). In any case, and in agreement with
a previous report [11], our results indicate that binding of R6 to PP1c and PP1 glycogenic sub-
strates are independent processes, although impairment of any of them results in the same loss
of functionality in glycogen homeostasis.
We also report a novel functional domain in R6 involved in binding to 14-3-3 proteins
(RARS74LP) (Fig 7). This domain is absent in other glycogen targeting subunits as GL or R5/
PTG (Fig 1A); in fact, we were not able to detect any interaction of these glycogenic subunits
Fig 6. Binding of 14-3-3 proteins to R6 prevents its lysosomal degradation. A) R6-S74Amutant possesses a shorter half-life than wild type protein.
Hek293 cells were transfected with pFLAG-R6 wt or pFLAG-R6-S74A plasmids. 24 hours after transfection, cells were treated with cycloheximide (300 μM)
to block protein synthesis. At the indicated times, cell extracts (30 μg) were analyzed byWestern blotting using anti-FLAG and anti-tubulin (as loading
control). A representative western blot is shown on the left panel. On the right panel, the intensity of the bands related to the levels of tubulin is plotted and
normalized respect to the values at time 0 (bars indicate the standard deviation of at least three independent experiments; **p < 0.01). B) R6-S74A protein is
degraded by the lysosomal pathway. Hek293 cells were transfected with pFLAG-R6-S74A plasmid. Eighteen hours after transfection, cells were treated with
ammonium chloride (20 mM)/ leupeptin (100 μM) or MG132 (5 μM) for six hours. Then, cells were lysed and extracts (30 μg) were analyzed by
immunoblotting using anti-FLAG antibody and anti-tubulin as loading control. The intensity of the bands related to the levels of tubulin is plotted (bars indicate
standard deviation of at least three independent experiments; *p < 0.05).
doi:10.1371/journal.pone.0131476.g006
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with 14-3-3 proteins by yeast two-hybrid (not shown). Mutation in the critical Ser74 residue
of R6 disrupts binding to 14-3-3ε proteins, although it still allows the binding to PP1c and to
PP1 glycogenic substrates. As different mass spectrometry analyses indicate that Ser74 is
phosphorylated in vivo ([32], [33], [34], [35]), binding of R6 to 14-3-3 proteins could protect
this site from dephosphorylation and prevent the rapid degradation of the protein by the
lysosomal pathway. It is surprising that a form that cannot be phosphorylated at Ser74 (and
hence it cannot bind 14-3-3 proteins) presented hyper-glycogenic properties. In our hands,
the expression of even very low amounts of the R6-S74A protein induced the production of
high levels of glycogen. Perhaps this R6-S74A protein has better dephosphorylation kinetics
against glycogenic enzymes or, alternatively, it could affect other unknown regulators of gly-
cogen synthesis. The fact that the R6-S74A form is very unstable may define protein degrada-
tion as a novel pathway in the control of the glycogenic properties of R6.
In conclusion, in this work we present strong evidence demonstrating the functionality of
different protein domains in R6: the PP1c-binding motif, the PP1 substrate motif and the 14-3-
3 protein binding motif. All of them play their independent role in providing a docking region
for interaction with their corresponding partners.
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